Ecaflo™ Technology Provides Cover Story For Leading Medical Journal

As further evidence of the significant impact made by Ecaflo™’s non-toxic and environmentally friendly solutions on the global water treatment market, the current issue of a prominent UK medical publication features an article on Ecaflo™ technology as its cover story.

Heralded as a ‘highly-effective alternative to the use of costly and aggressive chemical based technology’, the full-page article in The Clinical Services Journal (July 2006) highlights the broad-spectrum of uses for Ecaflo™ technology in the clinical environment and outlines the key benefits of Ecaflo™ for the healthcare sector.

An estimated 5,000 patients die prematurely every year in England from healthcare-acquired infections while thousands more suffer the effects of infections caught during their treatment. The unique ability of the Ecaflo product, Ecasol™, to destroy even methicillin resistant bacteria (MRSA), means that literally thousands of lives could be saved annually through the use of Ecaflo™ technology in the area of hospital infection control.

Ecaflo™ technology has already been declared as a ‘ground-breaking development’ in the war against pathogens and exposure of this magnitude in such an esteemed medical journal provides further validation that the medical and scientific communities are accepting and embracing Ecaflo™ technology as the ultimate solution to water treatment and hospital infection control.